Cargando…
An Innovative Approach to Address Neurodegenerative Diseases through Kinase-Targeted Therapies: Potential for Designing Covalent Inhibitors
Owing to the dysregulation of protein kinase activity in various diseases such as cancer and autoimmune, cardiovascular, neurodegenerative, and inflammatory conditions, the protein kinase family has emerged as a crucial drug target in the 21st century. Notably, many kinases have been targeted to add...
Autores principales: | Bhujbal, Swapnil P., Hah, Jung-Mi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10537995/ https://www.ncbi.nlm.nih.gov/pubmed/37765103 http://dx.doi.org/10.3390/ph16091295 |
Ejemplares similares
-
An Intriguing Purview on the Design of Macrocyclic Inhibitors for Unexplored Protein Kinases through Their Binding Site Comparison
por: Bhujbal, Swapnil P., et al.
Publicado: (2023) -
Generation of Non-Nucleotide CD73 Inhibitors Using a Molecular Docking and 3D-QSAR Approach
por: Bhujbal, Swapnil P., et al.
Publicado: (2021) -
Design of Novel IRAK4 Inhibitors Using Molecular Docking, Dynamics Simulation and 3D-QSAR Studies
por: Bhujbal, Swapnil P., et al.
Publicado: (2022) -
Design and Synthesis of Aminopyrimidinyl Pyrazole Analogs as PLK1 Inhibitors Using Hybrid 3D-QSAR and Molecular Docking
por: Bhujbal, Swapnil P., et al.
Publicado: (2022) -
Molecular Modelling Studies on Pyrazole Derivatives for the Design of Potent Rearranged during Transfection Kinase Inhibitors
por: Bhujbal, Swapnil P., et al.
Publicado: (2021)